Research & Education

5th Webinar: IASLC Grand Rounds Series- Screening for Lung Cancer in High-Risk Individuals: Risks versus Benefit

Recording now available.

The Fifth webinar in the series: IASLC Grand Rounds Series - Screening for Lung Cancer in High-Risk Individuals: Risks versus Benefit took place on May 14th at 8:00 pm EDT.

James Jett, MD

Director, Clinical and Translational Research Section
Professor
Department of Medicine
Division of Oncology, Cancer Center

National Jewish Health

 

Ramaswamy Govindan, MD - Program Chair

Co-Director, Section of Medical Oncology

Professor of Medicine

Division of Oncology

Washington University School of Medicine

The IASLC Lung Cancer Grand Rounds Series continues with a live webinar on May 14, 2014. In this one hour session - Dr. Jett will address the current status of screening for early detection and treatment of lung cancer in high-risk individuals with an emphasis on risks versus benefits. Several illustrative case studies will also be presented. Dr. Ramaswamy Govindan will moderate an audience question/answer and discussion session during which there will be ample opportunity to submit questions and comments via internet chat to Dr. Jett.

Following the overview, several relevant case studies will be reviewed and discussed by Drs. Govindan and Jett. There will be ample opportunity to submit questions and comments via internet chat to the faculty.

Watch Webinar

CME INFO:

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.

If you are interested in obtaining the CME Credits for these sessions you must indicate this when you register for the program.

 

This series is supported in part by unrestricted educational grants provided by Bristol-Myers Squibb Co., Celgene and Genentech